Clonal analysis of B-cell response in pemphigus course: Toward more effective therapies

Research output: Contribution to journalArticlepeer-review

Abstract

In this issue, Hammers et al. report the first longitudinal study of B-cell responses in pemphigus vulgaris. They show persistence of the same sets of anti-desmoglein 3 (Dsg3) B-cell clones over time in two patients with active disease, suggesting that escape from tolerance is not a frequent event. In addition, the disappearance of anti-Dsg3 B-cell clones in two patients during long-term rituximab-induced remission supports the therapeutic potential of rituximab.

Original languageEnglish
Pages (from-to)651-654
Number of pages4
JournalJournal of Investigative Dermatology
Volume135
Issue number3
DOIs
Publication statusPublished - Mar 12 2015

ASJC Scopus subject areas

  • Dermatology
  • Biochemistry
  • Cell Biology
  • Molecular Biology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Clonal analysis of B-cell response in pemphigus course: Toward more effective therapies'. Together they form a unique fingerprint.

Cite this